Shift work increases diabetes and heart disease risk

April 02, 2019

With over 20% of the population in industrial countries engaging shift work - in sectors such as healthcare and transportation - we urgently need to understand its health burden (1).

Many studies have shown that shift work is associated with heart and metabolic diseases, but new research in Experimental Physiology has clarified how shift work can have a long-term effect on the risk of heart disease and diabetes.

The study specifically suggested that shift work has a negative impact on the way a type of fat (called triglycerides) is broken down, as well as on the way sugar is utilised in our bodies. Both of these increase the risk of heart disease and diabetes because they affect how our body processes sugar and fat.

Researchers at the University College of Medical Sciences, University of Delhi conducted the research on two groups of healthcare workers. The first group included nurses, doctors and other healthcare workers aged 20 to 40 of both sexes who had not done night shift in the last one year or ever and had normal blood sugar levels. The second group was of the same professional background and age, but involved in rotational night shift duties (more than 4 nights duties per month at least for last one year) and had normal blood sugar levels.

Blood sugar levels were measured using an oral glucose tolerance test. Then, after 12 hours of overnight fasting, participants were given a high fat meal. Fasting insulin levels, and triglyceride levels, after fasting and after the meal, were measured in all of the study participants. These were compared between health care workers with and without night shift duties.

Lead author on the study, SV Madhu said:

"This study gives us a better understanding of why shift work is associated, in the long-term, with heart and metabolic diseases, helping us work towards reducing the incidence of heart disease, diabetes and obesity in the future."
-end-


The Physiological Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.